AIMM

Type: Public
On the web: http://www.autoimmuneinc.com
Employees: 2

AutoImmune develops drugs to treat immune system and inflammatory diseases -- or at least it would like to. It believes delivering therapeutic proteins through mucous membranes (e.g., oral drugs) prevents them from being attacked by the body as foreign invaders. Drug candidate Colloral failed to win FDA approval to treat rheumatoid arthritis, so AutoImmune sells it as a nutraceutical through a joint venture with Deseret Laboratories (Colloral LLC). The company licenses its mucosal tolerance technology to other drugmakers such as Teva Pharmaceutical, Eli Lilly, and BioMS Medical.

Key numbers for fiscal year ending December, 2008:
Sales: $0.3M
One year growth: 7.5%
Net income: ($0.3)M

Officers:
Chairman, President, and CEO: Robert C. (Bob) Bishop
Director Finance and Treasurer: Biopharmaceuticals & Biotherapeutics

Competitors:
Pharming
Rigel Pharmaceuticals
TolerRx

(AGP Inline Memory Module) A memory card that plugs into the AGP port. It augments the display memory on motherboards that already have AGP circuits built in. See AGP.

Download Computer Desktop Encyclopedia to your iPhone/iTouch